Treadmill gait analysis characterizes gait alterations in parkinson's disease and amyotrophic lateral sclerosis mouse models

Journal of Motor Behavior

Volumn 42, Issue 1, 2009, Pages 1-4

  Hampton, Thomas G ^a   Amende, Ivo ^b  

^a Mouse Specifics Inc   (United States)

^b TUFTS UNIVERSITY   (United States)

Author keywords

Amyotrophic lateral sclerosis; Gait; MPTP; Parkinson's disease; SOD1 G93A

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; ALANINE; COPPER ZINC SUPEROXIDE DISMUTASE; GLYCINE; NEUROTOXIN; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ARTICLE; C57BL MOUSE; CHEMICALLY INDUCED DISORDER; DISEASE MODEL; EXERCISE TEST; GAIT; GENETICS; MOUSE; PARKINSON DISEASE; PATHOPHYSIOLOGY;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ALANINE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE MODELS, ANIMAL; EXERCISE TEST; GAIT; GLYCINE; MICE; MICE, INBRED C57BL; NEUROTOXINS; PARKINSON DISEASE, SECONDARY; SUPEROXIDE DISMUTASE;

EID: 75149127388     PISSN: 00222895     EISSN: None     Source Type: Journal    
DOI: 10.1080/00222890903272025     Document Type: Article

References (30)

1. Amende, I.,Kale,A.,McCue,S.,Glazier, S.,Morgan, J. P.,&Hampton, T. G. (2005). Gait dynamics in mouse models of Parkinson's disease and Huntington's disease [Electronic version]. Journal of Neuroengineering and Rehabilitation, 2, 20. Retrieved October 1, 2009, from http://www.jneuroengrehab.com/content/2/1/ 20
2. Amino, T., Uchihara, T., Tsunekawa, H., Takahata, K., Shimazu, S., & Mizusawa, H., et al. (2008). Myocardial nerve fibers are preserved in MPTP-treated mice, despite cardiac sympathetic dysfunction. Neuroscience Research, 60, 314-318.
3. Andrus, P. K., Fleck, T. J., Gurney, M. E., & Hall, E. D. (1998). Protein oxidative damage in a transgenic mouse model of familial amyotrophic lateral sclerosis. Journal of Neurochemistry, 71, 2041-2048.
4. Barńeoud, P., Lolivier, J., Sanger, D. J., Scatton, B., & Moser, P. (1997). Quantitative motor assessment in FALS mice: A longitudinal study. NeuroReport, 8, 2861-2865.
5. Barnes, N. J., Bradbury, A. J., Costall, B., Domeney, A. M., Kelly, M. E., & Naylor, R. J. (1986). Neuropharmacological manipulations with MPTP. Journal of Neural Transmission, Supplement, 20, 47-63.
6. Distad, B. J., Meekins, G. D., Liou, L. L., Weiss, M. D., Carter, G. T., & Miller, R. G. (2008). Drug therapy in amyotrophic lateral sclerosis. Physical Medicine and Rehabilitation Clinics of North America, 19, 633-651.
7. Faist, M., Xie, J., Kurz, D., Berger, W., Maurer, C., & Pollak, P., et al. (2001). Effect of bilateral subthalamic nucleus stimulation on gait in Parkinson's disease. Brain, 124, 1590-1600 (Pubitemid 32726772)
8. Fernagut, P. O., Diguet, E., Labattu, B., & Tison, F. (2002). A simple method to measure stride length as an index of nigrostriatal dysfunction in mice. Journal of Neuroscience Methods, 113, 123-130.
9. Fischer, L. R., Culver, D. G., Davis, A. A., Tennant, P., Wang, M., & Coleman, M., et al. (2005). The WldS gene modestly prolongs survival in the SOD1G93A fALS mouse. Neurobiology of Disease, 19, 293-300.
10. Fischer, L. R., Culver, D. G., Tennant, P., Davis, A. A., Wang M., & Castellano-Sanchez, A. et al. (2004). Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Experimental Neurology, 185, 232-240.
11. Guillot, T. S.,Asress, S. A., Richardson, J. R.,Glass, J. D.,&Miller, G. W. (2008). Treadmill gait analysis does not detect motor deficits in animal models of Parkinson's disease or amyotrophic lateral sclerosis. Journal of Motor Behavior, 40, 568-577.
12. Gurney, M. E., Pu, H., Chiu, A. Y., Dal Canto, M. C., Polchow, C. Y., Alexander, D. D., et al. (1994, June). Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science, 264, 1772-1775. (Pubitemid 24227760)
13. Hampton, T. G., Kale, A., McCue, S., Morgan, J. P., & Amende, I. (2006). Propranolol attenuates sympathetic hyperfunction, delays motor dysfunction, and prolongs life in a mouse model of amyotrophic lateral sclerosis. European Heart Journal, 27(Suppl.), 2161.
14. Hausdorff, J. M., Cudkowicz, M. E., Firtion, R., Wei, J. Y., & Goldberger, A. L. (1998). Gait variability and basal ganglia disorders: Stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Movement Disorders, 13, 428-437.
15. Jakowec, M. W., & Petzinger, G. M. (2004). 1-Methyl-4-Phenyl-1, 2, 3, 6-Tetrahydropyradine-lesioned model of Parkinson's disease with emphasis on mice and nonhuman primates. Comparative Medicine, 54, 497-513.
16. Kiaei, M., Petri, S., Kipiani, K., Gardian, G., Choi, D. K., & Chen, J., et al. (2006). Thalidomide and lenalidomide extend survival in a transgenic mouse model of amyotrophic lateral sclerosis. Journal of Neuroscience, 26, 2467-2473.
17. Kong, J., & Xu, Z. (1998). Massive mitochondrial degeneration In motor neurons triggers the onset of amyotrophic lateral sclerosis in mice expressing a mutant SOD1. Journal of Neuroscience, 18, 3241-3250.
18. Kurz, M. J., Pothakos, K., Jamaluddin, S., Scott-Pandorf, M., Arellano, C., & Lau, Y. S. (2007). A chronic mouse model of Parkinson's disease has a reduced gait pattern certainty. Neuroscience Letters, 429, 39-42.
19. Liebetanz, D., Baier, P. C., Paulus, W., Meuer, K., Bähr, M., & Weishaupt, J. H. (2007). A highly sensitive automated complex running wheel test to detect latent motor deficits in the mouse MPTP model of Parkinson's disease. Experimental Neurology, 205, 207-213.
20. Ren, J., Porter, J. E., Wold, L. E., Aberle, N. S., Muralikrishnan, D., & Haselton J. R. (2004). Depressed contractile function and adrenergic responsiveness of cardiac myocytes in an experimental model of Parkinson disease, the MPTP-treated mouse. Neurobiology of Aging, 25, 131-138.
21. Schütz, B., Reimann, J., Dumitrescu-Ozimek, L., Kappes-Horn, K., Landreth, G. E., & Schürmann, B., et al. (2005). The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase- G93A transgenic mice. Journal of Neuroscience, 25, 7805-7812.
22. Sedelis, M., Schwarting, R. K. W., & Huston, J. P. (2001). Behavioral phenotyping of the MPTP mouse model of Parkinson's disease. Behavioral Brain Research, 125, 109-125.
23. Stam, N. C., Nithianantharajah, J., Howard, M. L., Atkin, J. D, Cheema, S. S., & Hannan, A. J. (2008). Sex-specific behavioural effects of environmental enrichment in a transgenic mouse model of amyotrophic lateral sclerosis. European Journal of Neuroscience, 28, 717-723.
24. Sundström, E., Fredriksson, A., & Archer, T. (1990). Chronic neurochemical and behavioral changes in MPTP-lesioned C57BL/6 mice: A model for Parkinson's disease. Brain Research, 528, 181-188.
25. van Zundert, B., Peuscher, M. H., Hynynen, M., Chen, A., Neve, R. L., & Brown, R. H. Jr., et al. (2008). Neonatal neuronal circuitry shows hyperexcitable disturbance in a mouse model of the adult-onset neurodegenerative disease amyotrophic lateral sclerosis. Journal of Neuroscience, 28, 10864-10874.
26. Wallace, R.A., Boldry, R., Schmittgen, T., Miller, D.,&Uretsky, N. (1984). Effect of 1-methyl-4-phenyl-1,2,3,6 tetrahydropyridine (MPTP) on monoamine neurotransmitters in mouse brain and heart. Life Sciences, 35, 285-291.
27. Wang, H., Guan, Y., Wang, X., Smith, K., Cormier, K., & Zhu, S., et al. (2007). Nortriptyline delays disease onset in models of chronic neurodegeneration. European Journal of Neuroscience, 26, 633-641.
28. Willis, G. L., & Donnan, G. A. (1987). Histochemical, biochemical and behavioural consequences of MPTP treatment in C-57 black mice. Brain Research, 402, 269-274.
29. Wooley, C. M., Sher, R. B., Kale, A., Frankel, W. N., Cox, G. A., & Seburn, K. L. (2005). Gait analysis detects early changes in transgenic SOD1 (G93A) mice. Muscle and Nerve, 32, 43-50.
30. Yang, Y. R., Lee, Y. Y., Cheng, S. J., Lin, P. Y., & Wang, R. Y. (2008). Relationships between gait and dynamic balance in early Parkinson's disease. Gait and Posture, 27, 611-615.